Congenital heart disease - Clinical trials 

  • Clinical trials

Clinical trials for Congenital heart disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Congenital heart disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Congenital heart disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Congenital heart disease
Title Recruitment status Location
Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist Recruiting United Kingdom
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) Recruiting United Kingdom
International randomized double blind clinical study evaluating the efficacy and safety of clopidogrel 0.2mg/kg once daily versus placebo in neonates and infants with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt (e.g. modified Blalock Taussig shunt) - CLARINET Not Recruiting United Kingdom
The effect of red cell washing on serum biochemistry in neonates and infants undergoing surgery for complex congenital heart disease with cardiopulmonary bypass Not recruiting United Kingdom
A comparison of the effects of Sevoflurane and Isoflurane on cardiovascular parameters measured by cardiac magnetic resonance imaging in paediatric patients with congenital heart disease. A randomised controlled trial. Not recruiting United Kingdom
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children with Hemodynamically Significant Congenital Heart Disease Not Recruiting United Kingdom
Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation Not recruiting United Kingdom
Long-term safety study in patients included in CLARINET study with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt and for whom the shunt is still in place at one year of age - CLARINET LONG TERM Not Recruiting United Kingdom
International randomized double blind clinical study evaluating the efficacy and safety of clopidogrel 0.2mg/kg once daily versus placebo in neonates and infants with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt (e.g. modified Blalock Taussig shunt) - CLARINET Not Recruiting United Kingdom
Long-term safety study in patients included in CLARINET study with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt and for whom the shunt is still in place at one year of age - CLARINET LONG TERM Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member